Central centrifugal cicatricial alopecia (CCCA) is a scarring hair loss condition that usually begins at the crown and gradually spreads outward over time. In the earliest stages, it presents as mild scalp symptoms such as dryness and itchiness and brittle hair.  As the condition progresses, the hair loss occurs around the crown and the scalp can feel increasingly reactive.  In more advanced stages, the process becomes structural, and the scarring process starts.

Due to the scarring nature of CCCA, “recovery” takes place over two distinct stages. The first stage is stabilisation of the scalp area by reducing inflammation locally and improving immune competence systemically.  Success here is measured by no further spread and no progression of scarring features.  The next stage is recovery and supported regrowthof hair where follicles are still partially or wholly structurally intact. 

Phase 1:

0 to 4 months

This is the diagnosis and activity-reduction phase. The clearest early markers are symptom-based: itch, burning, tenderness, and flare frequency should begin to reduce if disease activity is being controlled. Shedding may continue and can look unchanged at first, because hair cycling and shedding lag months behind changes in inflammation. Visible density change is not a reliable expectation at this stage. 

Phase 2:

4 to 8 months

This is the stabilisation phase. The main outcome is reduced volatility: fewer flares, less persistent itch, and a more predictable scalp day-to-day. Shedding can become easier to track, but it may not stop completely. The core marker here is containment, meaning the affected area is not expanding and there is no new loss of follicular openings in the most active zones. Any early density improvement, if seen, is usually subtle and localised to areas that were thinning rather than fully scarred.

Phase 3:

8 to 12 months

This is the recovery phase for viable follicles. If stability has been maintained, this is the earliest window where gradual improvement in coverage may become noticeable in non-scarred areas. Shedding should be less inflammatory in character and less erratic. Changes are best judged by repeat photography and trichoscopy rather than day-to-day perception.

Phase 4:

12 to 24 months

This is the consolidation phase. In early to mid-stage CCCA, this period is often where the best cosmetic improvement is seen alongside sustained symptom control.  Here is where growth from the most affected areas will be seen.  At this stage regrowth can be supported by minoxidil, injectables or LED therapy.

Summary

CCCA timelines are extended due to the extent of changes required to halt the condition: activity and structure. Inflammatory and immune activity can settle within months, while structural changes to the dermis are slow and metabollicaly dependent. Stabilisation, although only one stage in the treatment pathway, is still  a clinically meaningful result in CCCA because it prevents further fibrosing change, and any regrowth is most plausible where follicle structures remain intact.